Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease.

Foley P, Bradford HF, Docherty M, Fillit H, Luine VN, McEwen B, Bucht G, Winblad B, Hardy J.

J Neurol. 1988 Nov;235(8):466-71.

PMID:
3210051
2.

Antibodies in serum of patients with Alzheimer's disease cause immunolysis of cholinergic nerve terminals from the rat cerebral cortex.

Bradford HF, Foley P, Docherty M, Fillit H, Luine VN, McEwen B, Bucht G, Winbald B, Hardy J.

Can J Neurol Sci. 1989 Nov;16(4 Suppl):528-34.

PMID:
2804815
3.

Cholecystokinin protects cholinergic neurons against basal forebrain lesion.

Sugaya K, Takahashi M, Kubota K.

Jpn J Pharmacol. 1992 May;59(1):125-8.

4.

The immunolysis, isolation, and properties of subpopulations of mammalian brain synaptosomes.

Bradford HF, Docherty M, Wu JY, Cash CD, Ehret M, Maitre M, Joh TH.

Neurochem Res. 1989 Apr;14(4):301-10.

PMID:
2569672
5.
6.

Anti-brain spectrin immunoreactivity in Alzheimer's disease: degradation of spectrin in an animal model of cholinergic degeneration.

Fernández-Shaw C, Marina A, Cazorla P, Valdivieso F, Vázquez J.

J Neuroimmunol. 1997 Jul;77(1):91-8.

PMID:
9209273
7.

Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer's disease.

Orta-Salazar E, Cuellar-Lemus CA, Díaz-Cintra S, Feria-Velasco AI.

Neurologia. 2014 Oct;29(8):497-503. doi: 10.1016/j.nrl.2012.10.007. Epub 2013 Feb 22. Review. English, Spanish.

8.

Antibodies to cholinergic neurons in Alzheimer's disease.

Chapman J, Bachar O, Korczyn AD, Wertman E, Michaelson DM.

J Neurochem. 1988 Aug;51(2):479-85.

PMID:
3292704
9.
11.

The cholinergic system and the excitatory amino acids in Alzheimer's disease.

Bowen D.

Acta Neurol Scand Suppl. 1990;129:15-6. No abstract available.

PMID:
2220318
12.

Determination of high-affinity choline uptake (HACU) and choline acetyltransferase (ChAT) activity in the same population of cultured cells.

Ray B, Simon JR, Lahiri DK.

Brain Res. 2009 Nov 10;1297:160-8. doi: 10.1016/j.brainres.2009.07.096. Epub 2009 Aug 4.

13.

Neurochemical characterization of an antimony-choline analog in rat cortical synaptosomes.

Meyer EM, Barrnett RJ, Cooper JR.

J Neurochem. 1982 Aug;39(2):321-6.

PMID:
7045287
14.

In vitro measurements of cholinergic activity in brain regions of hibernating ground squirrels.

Stanton TL, Johnson GV.

Brain Res Bull. 1987 May;18(5):663-7.

PMID:
3607532
15.
16.

Challenging assumptions about Alzheimer's disease: mild cognitive impairment and the cholinergic hypothesis.

Morris JC.

Ann Neurol. 2002 Feb;51(2):143-4. Review. No abstract available.

PMID:
11835369
17.
18.

Relationship of choline uptake to acetylcholine synthesis and release.

Marchbanks RM, Wonnacott S.

Prog Brain Res. 1979;49:77-88. Review. No abstract available.

PMID:
390614
19.

Experimental immune-mediated damage of septal cholinergic neurons.

Kálmán J, Engelhardt JI, Le WD, Xie W, Kovacs I, Kása P, Appel SH.

J Neuroimmunol. 1997 Jul;77(1):63-74.

PMID:
9209270
20.

Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex.

Beal MF, Clevens RA, Chattha GK, MacGarvey UM, Mazurek MF, Gabriel SM.

J Neurochem. 1988 Dec;51(6):1935-41.

PMID:
2460590

Supplemental Content

Support Center